October 23, 2026

Abivax SA (ABVX) Stock Analysis: A Biotech Contender with 81% Potential Upside

Abivax SA (ABVX), a France-based biotechnology firm, is making waves in the healthcare sector with its promising pipeline and strategic focus on chronic inflammatory diseases. Despite..

SIGA Technologies Inc. (SIGA) Stock Analysis: Healthcare Innovator at a Crossroads

SIGA Technologies Inc. (NASDAQ: SIGA), a notable entity within the healthcare sector, resides in the highly specialized industry of drug manufacturing, with a focus on specialty..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A 131% Potential Upside in Biotech Innovation

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out as an intriguing player in the biotechnology sector, particularly for investors with a keen eye on the burgeoning field..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: A Biotech Pioneer Facing Challenging Financial Metrics

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the forefront of synthetic biology, crafting a platform designed to revolutionize cell engineering. Operating primarily within the healthcare..

Celcuity Inc. (CELC) Stock Analysis: Exploring a 135.92% Potential Upside in the Biotech Arena

For investors with an eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents a compelling case. With its focus on innovative targeted therapies for treating..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 50% Potential Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with its innovative approach to drug discovery, particularly in targeted oncology and genetic diseases. Headquartered..

Autolus Therapeutics (AUTL) Stock Analysis: Unpacking a 452% Potential Upside in Biotech Innovation

Autolus Therapeutics plc (NASDAQ: AUTL), a London-based biopharmaceutical innovator, is making waves in the healthcare sector with its promising pipeline of T cell therapies targeting cancer..

Inventiva S.A. (IVA): Consensus Shows 322% Upside Potential Amid Biotech Breakthroughs

Investors with a penchant for high-risk, high-reward opportunities should keep a close eye on Inventiva S.A. (NASDAQ: IVA), a promising player in the biotechnology sector. Headquartered..

Kamada Ltd. (KMDA) Stock Analysis: Unveiling a Potential 74.64% Upside in Healthcare

Kamada Ltd. (NASDAQ: KMDA) is capturing the attention of investors with its promising potential for growth in the healthcare sector. Specializing in plasma-derived protein therapeutics, the..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unlocking an 80% Upside Potential

Investors eyeing biotechnology stocks with significant growth potential may want to consider Stoke Therapeutics, Inc. (NASDAQ: STOK). A key player in the healthcare sector, Stoke Therapeutics..

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Gem with 32.64% Potential Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is capturing investor attention with its robust growth potential and promising pipeline of G protein-coupled receptor (GPCR) therapies...

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A 50% Upside Potential Amid Innovative Drug Development

For investors with a keen eye on the healthcare sector, Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) presents a fascinating opportunity, primarily due to its strong buy ratings..

AtaiBeckley Inc. (ATAI) Stock Analysis: Exploring the 137% Revenue Growth and Strategic Position in the Biotechnology Sector

AtaiBeckley Inc. (ATAI) is making waves in the biotechnology sector with a remarkable 137% revenue growth, capturing the attention of investors seeking high-potential opportunities in the..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A Look at Its Stable Valuation Amidst Transformative Changes

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) finds itself in a unique position within the biotechnology sector, providing investors with an intriguing narrative. As a company specializing in..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth in Cancer Genomics Despite Financial Challenges

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector specializing in diagnostics and research, has captured attention with its innovative approach in the realm..

Bicycle Therapeutics (BCYC) Stock Analysis: Exploring a Potential 161% Upside Opportunity

Bicycle Therapeutics plc (NASDAQ: BCYC), a United Kingdom-based biotechnology company, is capturing attention in the healthcare sector, notably for its innovative approach to drug development through..

EyePoint, Inc. (EYPT) Stock Analysis: A Biotech with Massive 1,870% Upside Potential

EyePoint, Inc. (NASDAQ: EYPT), a biotechnology company focused on innovative treatments for serious retinal diseases, presents a fascinating opportunity for investors seeking high-risk, high-reward plays in..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with 452% Upside Potential

Sionna Therapeutics, Inc. (NASDAQ:SION) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly in treating cystic fibrosis (CF). Despite its..

Dianthus Therapeutics, Inc. (DNTH) Investor Outlook: A 79% Upside Potential in the Biotech Sector

Dianthus Therapeutics, Inc. (DNTH), a promising player in the biotechnology sector, is capturing investor attention with its robust pipeline focused on combating severe autoimmune diseases. With..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Biotechnology Innovator Eyes 74% Upside

Keros Therapeutics, Inc. (NASDAQ: KROS), a dynamic player in the healthcare sector, is making waves in the biotechnology industry with its focus on innovative treatments for..

Search

Funds

October 23, 2026

Search

Funds

October 23, 2026

FTSE 100

Funds